BOLZATI, CRISTINA
 Distribuzione geografica
Continente #
NA - Nord America 4.030
AS - Asia 2.381
EU - Europa 1.021
SA - Sud America 340
AF - Africa 321
Continente sconosciuto - Info sul continente non disponibili 50
OC - Oceania 42
Totale 8.185
Nazione #
US - Stati Uniti d'America 3.835
SG - Singapore 754
CN - Cina 512
VN - Vietnam 368
HK - Hong Kong 211
IT - Italia 211
BR - Brasile 207
FR - Francia 94
DE - Germania 91
FI - Finlandia 90
PL - Polonia 82
IN - India 61
BD - Bangladesh 55
NL - Olanda 46
GB - Regno Unito 44
SE - Svezia 44
RU - Federazione Russa 43
CA - Canada 39
TR - Turchia 33
IQ - Iraq 32
JP - Giappone 30
ZA - Sudafrica 29
AR - Argentina 28
SA - Arabia Saudita 22
CI - Costa d'Avorio 21
ES - Italia 21
PH - Filippine 21
UZ - Uzbekistan 20
ID - Indonesia 18
IE - Irlanda 18
PY - Paraguay 18
LB - Libano 17
PK - Pakistan 17
TH - Thailandia 17
UA - Ucraina 17
CO - Colombia 16
GR - Grecia 16
VE - Venezuela 16
MX - Messico 15
KZ - Kazakistan 14
AL - Albania 13
AT - Austria 13
BO - Bolivia 13
MY - Malesia 13
NC - Nuova Caledonia 13
CL - Cile 12
EC - Ecuador 12
IL - Israele 12
IS - Islanda 12
KR - Corea 12
MG - Madagascar 12
PA - Panama 12
BJ - Benin 11
CW - ???statistics.table.value.countryCode.CW??? 11
CZ - Repubblica Ceca 11
HR - Croazia 11
HU - Ungheria 11
TN - Tunisia 11
AZ - Azerbaigian 10
DZ - Algeria 10
GT - Guatemala 10
JM - Giamaica 10
KH - Cambogia 10
LT - Lituania 10
MA - Marocco 10
NP - Nepal 10
PT - Portogallo 10
SK - Slovacchia (Repubblica Slovacca) 10
SN - Senegal 10
TW - Taiwan 10
UG - Uganda 10
AU - Australia 9
BE - Belgio 9
BW - Botswana 9
BY - Bielorussia 9
CH - Svizzera 9
CR - Costa Rica 9
DJ - Gibuti 9
GE - Georgia 9
KE - Kenya 9
NZ - Nuova Zelanda 9
PR - Porto Rico 9
SO - Somalia 9
AM - Armenia 8
BS - Bahamas 8
CY - Cipro 8
HN - Honduras 8
JO - Giordania 8
ME - Montenegro 8
NI - Nicaragua 8
RS - Serbia 8
ZW - Zimbabwe 8
DO - Repubblica Dominicana 7
GA - Gabon 7
GM - Gambi 7
LA - Repubblica Popolare Democratica del Laos 7
LV - Lettonia 7
MK - Macedonia 7
MU - Mauritius 7
MW - Malawi 7
Totale 7.824
Città #
Ashburn 466
Singapore 444
San Jose 390
Fairfield 333
Chandler 254
Hong Kong 199
Houston 187
Woodbridge 181
Ann Arbor 163
Santa Clara 134
Seattle 109
Cambridge 104
Beijing 101
Wilmington 97
Hanoi 94
Ho Chi Minh City 93
Los Angeles 78
Boardman 67
Bytom 60
New York 56
Princeton 41
The Dalles 41
Medford 39
Dong Ket 38
Helsinki 38
Lauterbourg 36
Padova 36
Munich 34
Des Moines 32
San Diego 30
Nanjing 24
São Paulo 23
Buffalo 22
Abidjan 21
Tokyo 20
Turku 20
Dallas 19
Da Nang 18
Milan 18
Montreal 18
Atlanta 17
Baghdad 17
Orem 17
Roxbury 16
Tashkent 16
Brooklyn 14
Dublin 14
Haiphong 14
Hefei 14
Johannesburg 14
Guangzhou 13
Noumea 13
Warsaw 13
Boston 12
Columbus 11
Frankfurt am Main 11
Panama City 11
Phoenix 11
Antananarivo 10
Chennai 10
Cotonou 10
Council Bluffs 10
Dakar 10
Kampala 10
Redondo Beach 10
Willemstad 10
Athens 9
Jeddah 9
Naples 9
Reykjavik 9
Baku 8
Belo Horizonte 8
Chicago 8
Harare 8
London 8
Managua 8
Nairobi 8
Nassau 8
Phnom Penh 8
Shanghai 8
Stockholm 8
Amsterdam 7
Bangkok 7
Biên Hòa 7
Charlotte 7
Dushanbe 7
Istanbul 7
Jiaxing 7
Kuala Lumpur 7
Limassol 7
Mumbai 7
Pune 7
Rio de Janeiro 7
Riyadh 7
Tianjin 7
Toronto 7
Vientiane 7
Washington 7
Almaty 6
Amman 6
Totale 4.761
Nome #
[99mTc(N)PNP]-scaffold for SPECT of multidrug resistance: Early in-vitro study 417
Assessment of the best N3− donors in preparation of [M(N)(PNP)]-based (M=99mTc-; 188Re) target-specific radiopharmaceuticals: Comparison among succinic dihydrazide (SDH), N-methyl-S-methyl dithiocarbazate (HDTCZ) and PEGylated N-methyl-S-methyl dithiocarbazate (HO2C-PEG600-DTCZ) 316
Folic Acid-Conjugated Europium Complexes as Luminescent Probes for Selective Targeting of Cancer Cells 265
Development of 177Lu-scFvD2B as a Potential Immunotheranostic Agent for Tumors Overexpressing the Prostate Specific Membrane Antigen 264
99mTc(N)(DASD)(pnpn)]+ (DASD=1,4-dioxa-8-azaspiro[4,5]decandithiocarba pnpn=bisphosphinoamine) for myocardial imaging 256
Transglutaminase-mediated conjugation and nitride-technetium-99m labelling of a bis(thiosemicarbazone) bifunctional chelator 244
[99mTc][Tc(N)(DASD)(PNPn)]+ (DASD=1,4-dioxa-8-azaspiro[4,5]decandithiocarbamate, PNPn=bisphosphinoamine) for myocardial imaging: synthesis, pharmacological and pharmacokinetic studies 244
99mTc(N)-DBODC(5), a potential radiolabeled probe for SPECT of multidrug resistance: in vitro study 244
Melanoma targeting with [99mTc(N)(PNP3)]-labeled α-melanocyte stimulating hormone peptide analogs: Effects of cyclization on the radiopharmaceutical properties 236
Biologically relevant Cu2+ complexes with a tridentate phenanthroline analogue: structural properties and DNA damage 225
Synthesis and Characterization of [MIII(PS)2(L)] Mixed-Ligand Compounds (M = Re,99Tc; PS = Phosphinothiolate; L = Dithiocarbamate) as Potential Models for the Development of New Agents for SPECT Imaging and Radiotherapy 221
Pharmacological characterization of α-MSH-derivatives 218
Preclinical dosimetric studies of 177Lu-scFvD2B and comparison with 177Lu-PSMA-617 and 177Lu-iPSMA endoradiotherapeutic agents 218
A bis(thiosemicarbazone) bifunctional chelating agent for nitrido-technetium-99m and copper-64 based radiopharmaceuticals 216
TcIII-based mixed complexes for the design and the development of new SPECT tracers 203
Impact of Different [Tc(N)PNP]-Scaffolds on the Biological Properties of the Small cRGDfK Peptide: Synthesis, In Vitro and In Vivo Evaluations 199
A bis(thiosemicarbazone) bifunctional chelating agent for Nitrido-Technetium-99m and Copper-64 based radiopharmaceuticals 196
Comparison of preclinical dosimetric studies of 177Lu-scFvD2B, 177Lu-PSMA-617 and 177Lu-iPSMA. 191
Synthesis and characterization of rhenium(III) complexes with (Ph2PCH2CH2)2NR diphosphinoamine ligands 191
Synthesis a new radiopharmaceutical for prostate cancer SPECT imaging 188
99mTc(N)-DBODC(5) from cardiology to oncology: preliminary in vitro study 186
[99mTc(N)(DASD)(PNPn)]+ Compounds as Myocardial Perfusion Imaging Agents. 175
Radiation effective dose assessment of [51Mn]- and [52Mn]-chloride 172
Chelating Systems for 99mTc/188Re in the Development of Radiolabeled Peptide Pharmaceuticals 170
Radiopharmacological characterization of 64Cu-labeled α-MSH analogs for potential use in imaging of malignant melanoma 169
64Cu-Labelled compounds with dithiocarbamate ligands for theragnostic applications: preliminary in vitro studies 166
Nitrido technetium-99m core in radiopharmaceutical applications: Four decades of research 166
Conjugation and characterization of a new prostate cancer theranostic radiopharmaceutical 165
[99mTc(N)(DBODC)(5)]+: sub-cellular distribution and metabolism studies of this new potential myocardial imaging agent 164
Dosimetry of 51MnCl2 and 52MnCl2 for PET application 163
Synthesis and Characterization of Novel Hexacoordinated, Asymmetrical M(III) (M = Re, 99gTc) Complexes as Models for the Development of Potential Tracers for SPECT Imaging and Radiotherapy 159
99mTc(N)-DBODC(5), a potential probe for SPECT imaging of multidrug resistance: in vitro study 157
Synthesis and biological evaluation of new [99mTc(N)(PNPn)]2+-labeled cRGDfK peptide: preliminary studies 156
[Re-188(N)(cys similar to)(PNP)](+/0) mixed ligand compounds as models for target specific agents 153
Synthesis and characterization of novel asymmetrical M(III) (M = Re, 99gTc) complexes as models for the development of potential tracers for SPECT imaging and radiotherapy 147
Synthesis and biological evaluation of new [Tc(N)(R2PS)]-based mixed compounds as analogues of WAY 100635 145
Method for labeling of sensitive and thermosensitive targeting biomolecules with technetium based compounds 144
Development of a new prostate cancer theranostic radiopharmaceutical 142
Zirconium immune-complexes for PET molecular imaging: Current status and prospects 136
Synthesis and biological evaluation of new [99mTc(N)(PNPn)]2+-labeled cRGDfK peptide: preliminary studies 136
Insights into the failure of the potential, neutral myocardial imaging agent TcN-NOET: physicochemical identification of by-products and degradation species 135
Synthesis and Characterization of Novel Asymmetrical M(III) (M = Re, 99gTc) Complexes as Models for the Development of Potential Tracers for SPECT Imaging and Radiotherapy 127
Totale 8.185
Categoria #
all - tutte 23.482
article - articoli 15.390
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 341
selected - selezionate 0
volume - volumi 0
Totale 39.213


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022410 0 52 43 27 21 30 23 43 18 14 33 106
2022/2023474 78 59 9 76 72 56 4 22 50 14 25 9
2023/2024293 18 51 46 20 28 23 24 11 5 22 21 24
2024/20251.132 9 77 43 43 190 24 65 103 89 18 195 276
2025/20264.133 241 324 478 567 434 174 662 310 452 243 200 48
2026/2027409 140 269 0 0 0 0 0 0 0 0 0 0
Totale 8.185